Lowering the TG/HDL-C ratio can prevent type 2 diabetes and type 2 diabetes.

Published Date: 17 Mar 2023

Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.

Read Full News

Latest News

US FDA Sends 25 Letters to Telehealth Companies Over Claims on Compounded Weight-loss Drugs

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

Support Groups Boost Weight Loss in Patients With Obesity

Consistent engagement in a support group paired with lifestyle changes has been shown to be linked to notably greater weight loss in a community gastroenterology clinic weight-management program.

Sitting Less, More Light Activity May Reduce Pregnancy Risks

Pregnant individuals who sit for more than 10 hours daily face higher risks for adverse pregnancy outcomes, whereas about 7 hours of light-intensity activity daily is linked to a lower risk.

GLP-1s Tied to Lower Cancer Risk in Patients With Obesity

In a large observational study of adults with obesity without diabetes, GLP-1 receptor agonists were associated with a 41% lower incidence of obesity-associated cancers over 2 years.

German Government to Abandon Variable Drug Discounting Plans, Source Tells Reuters

Germany's government is replacing plans that would have introduced variable discounts on pharmaceuticals, ⁠a government source told Reuters on Monday, following opposition...

Male Fertility Not Harmed by GLP-1s and Maybe Helped

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Latest News

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

Consistent engagement in a support group paired with lifestyle changes has been shown to be linked to notably greater weight loss in a community gastroenterology clinic weight-management program.

Pregnant individuals who sit for more than 10 hours daily face higher risks for adverse pregnancy outcomes, whereas about 7 hours of light-intensity activity daily is linked to a lower risk.

In a large observational study of adults with obesity without diabetes, GLP-1 receptor agonists were associated with a 41% lower incidence of obesity-associated cancers over 2 years.

Germany's government is replacing plans that would have introduced variable discounts on pharmaceuticals, ⁠a government source told Reuters on Monday, following opposition...

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

News All Time

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Novo Nordisk said on Thursday it has identified a security incident in which certain information, including ⁠patient data from some clinical trials, was copied externally...

Tirzepatide Outperforms Conventional Care in Early Diabetes

Tirzepatide offered better glycemic control and greater weight loss than intensive conventional care in adults with early type 2 diabetes, a study finds.

AI-Guided Prep Improves Bariatric Surgery Consults

A structured, AI-supported metacognitive framework substantially enhances the quality of metabolic and bariatric surgery consultations.

PMOS: Insulin Resistance Affects Fertility and Pregnancy

Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications such as preeclampsia.

Over-the-Counter CGM Okayed for Kids

The US FDA extended the age of use for Dexcom’s Stelo down to 2 years.

Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits

The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options for targeted treatment.

Older Drug Reprograms White Blood Cells, Improves Blood Sugar in Type 1 Diabetes

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Oral GLP-1 Orforglipron Performs Well in Phase 3 T2D Trials

Phase 3 trials of the oral nonpeptide show glycemic and weight benefit when added to glargine and compared with dapagliflozin and oral semaglutide, but with somewhat lower tolerability.

GLP-1s Tied to Musculoskeletal Benefits in Obesity

Use of GLP-1s vs other antiobesity medications is linked to decreased risk for osteoporosis, fractures, disk degeneration, and osteoarthritis in adults with obesity.

AI Tool Detects Occult Pancreatic Cancer Months in Advance

A new AI model reliably identifies hidden pancreatic ductal adenocarcinoma on routine CT scans months before the clinical diagnosis of the disease.

Use Of GLP-1 Drugs Early in Pregnancy Should Not Cause Alarm, Analysis Suggests

Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is ⁠not a cause for alarm, a large new data...

Study Finds No Link Between Semaglutide and AMD Risk

Compared with other glucose-lowering drugs, semaglutide is not associated with the risk for neovascular age-related macular degeneration in adults with type 2 diabetes.

Recommended News For You

Breast density changes over time are associated with an increased risk of cancer.

Breast awareness: What to look for in your self-exam

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Combination therapy improves outcomes for advanced triple-negative breast cancer

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

Recommended Articles For You

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia 

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study looks into cancer-related harmful communication.

2.

France Expands 2026 Vaccination Rules Amid Resurgence

3.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

1.

Contemporary Insights in Oncology in the Digital Era

2.

Tumor Evolution: Signaling, Plasticity, and Intratumor Heterogeneity in Cancer

3.

Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests 

4.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

5.

From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot